Baker Biotech Capital , Llc Insider Profile
4 Followers
Baker Biotech Capital , Llc, Ten Percent Owner at Heron Therapeutics, holds 342.04K shares in Ocera Therapeutics (Ticker: OCRX), holds 1.48M shares in Genomic Health (Ticker: GHDX), holds 1.59M shares in XOMA Royalty Corporation (Ticker: XOMA). Most recently, Baker Biotech Capital , Llc Bought ― shares of Ocera Therapeutics on Mar 14, 2012 for an estimated value of $311.46K.
Baker Biotech Capital , Llc's Trading History
| OCRXOcera Therapeutics | Mar 14, 2012 | ― | Informative Buy | 311.46K | $612.25K | |
| GHDXGenomic Health | Mar 09, 2012 | ― | Informative Buy | 135.71K | $94.21M | |
| XOMAXOMA Royalty Corporation | Mar 08, 2012 | ― | Informative Buy | ― | $63.69M | |
| PCYCPharmacyclics | Feb 14, 2012 | ― | Informative Buy | 3.13M | ― | |
| GEVASynageva | Jan 09, 2012 | ― | Uninformative Buy | 4.72M | ― | |
| SGENSeagen | Jan 04, 2012 | ― | Informative Buy | 2.12M | $1.14B | |
| AUXLAuxilium | Aug 03, 2011 | ― | Informative Sell | 1.95M | ― | |
| INCYIncyte | Sep 23, 2010 | Director, Ten Percent Owner | Informative Sell | 5.91M | $352.75M | |
| HRTXHeron Therapeutics | Oct 27, 2009 | Ten Percent Owner | Informative Buy | ― | $406.88K | |
| BCRXBioCryst | Jun 01, 2009 | Ten Percent Owner | Informative Sell | 997.42K | $11.34M | |
| VPHMViropharma | May 08, 2009 | ― | Informative Buy | ― | ― | |
| ACGNAceragen | ― | ― | ― | $79.46K |
You May Also Like
Baker Biotech Capital , Llc insider profile FAQ
What is the percentage of profitable transactions made by Baker Biotech Capital , Llc?
The percentage of profitable transactions made by Baker Biotech Capital , Llc is 58%.
What is the average return per transaction made by Baker Biotech Capital , Llc?
The average return per transaction made by Baker Biotech Capital , Llc is 112.50%.
What stocks does Baker Biotech Capital , Llc hold?
Baker Biotech Capital , Llc holds: HRTX, INCY, SGEN, GHDX, BCRX, XOMA, OCRX, ACGN, AUXL, PCYC, GEVA, VPHM stocks.
What was Baker Biotech Capital , Llc’s latest transaction?
Baker Biotech Capital , Llc’s latest transaction was an Informative Buy of $311.46K.
What was Baker Biotech Capital , Llc's most profitable transaction?
Baker Biotech Capital , Llc’s most profitable transaction was an Informative Buy of PCYC stock on August 24, 2011. The return on the trade was 524.90%.
What is Baker Biotech Capital , Llc's role in Heron Therapeutics?
Baker Biotech Capital , Llc's role in Heron Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
